As seen in late April through mid-May, lab stocks continue to be strong so far in June. Over the past five weeks, the 14 publicly traded labs tracked by the G-2 Reports Laboratory Stock Index are up an impressive 32 percent over the past 13 weeks and 11 percent over the past five weeks for the week ended June 19, 2009. So far in 2009, the index is up 21 percent. The Nasdaq also continues to post gains, although the S&P 500 continues to decline—although not as much as in recent months. For 2009, the Nasdaq is up over 11 percent, while the S&P 500 is down 1.13 percent so far this year.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

July 2009 - Table of Contents

LIR July 2009 (full PDF issue)

G-2 Reports-Chi Solutions’ Outreach Survey Indicates Labs Leading in Profitability Measures, Falling Short on Bad Debt and DSO

LabCorp Plans to Acquire Monogram Biosciences for Approximately $155 Million

Senate Bill Proposes ‘Date of Service’ Policy Change That Will Benefit Labs

Genoptix, Myriad Genetics Lead in G-2 Reports’ First Quarter Benchmarking Analysis

Psychemedics Teams With UK’s Bupa to Market Hair Analysis Assay

Inside the Lab Industry: Washington G-2 Reports-Chi Solutions’ Latest Survey Finds Outreach Lab Profitability Over 20% and Annual Revenue Growth Over 3%

The C-Suite Perspective: Building a Business Case for Outreach

Agendia Boosts MammaPrint Sales Effort Through CLIA Lab Launch, Sales Force Expansion

GE’s $100 Million Stimulus Simplicity Program to Offer No-Interest Loans for EMR Products

CBLPath Opens Manhattan Facility

Adeona Pharma Buys Chicago’s Hartlab to Expand Degenerative Disease Diagnostic Offerings

Lab Stocks Continue Impressive Show of Strength; Up 11% Over Five Weeks, 32% Over Past 13 Weeks

Industry Buzz: CDC Seeks Help in Establishing Laboratory Best Practices